Product Liability Risks Cannabis Companies Must Consider

By David Kerschner and Aaron Levine (December 14, 2021, 5:35 PM EST) -- On Nov. 15, the States Reform Act was introduced into the U.S. House of Representatives, a bill that seeks to remove marijuana from Schedule I status under the Controlled Substances Act. This bill follows several others, including the Marijuana Opportunity Reinvestment and Expungement Act[1] and the Secure and Fair Enforcement Banking Act,[2] which were previously approved by the House.

There is little doubt that the popularity of cannabis and CBD products is growing, and some lawmakers are now looking to decrease cannabis regulation at the federal level and expand access. Indeed, a 2019 Gallup survey found that 14% of U.S. adults...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!